Pulmonx Corporation LUNG
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 6.20% | -4.62% | -8.66% | -4.91% | 5.47% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.20% | -4.62% | -8.66% | -4.91% | 5.47% |
| Cost of Revenue | -0.26% | -24.66% | -26.69% | -18.11% | 1.66% |
| Gross Profit | 8.39% | 3.13% | -1.82% | -0.28% | 6.83% |
| SG&A Expenses | -21.77% | -18.49% | -7.83% | -15.35% | 0.74% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -15.52% | -17.72% | -9.59% | -12.59% | 4.00% |
| Operating Income | 47.96% | 38.82% | 11.03% | 26.19% | -1.87% |
| Income Before Tax | 40.39% | 33.67% | 5.65% | 22.06% | 0.88% |
| Income Tax Expenses | 17.97% | -24.86% | 10.37% | 389.47% | -33.33% |
| Earnings from Continuing Operations | 39.86% | 33.57% | 5.50% | 20.87% | 1.32% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 39.86% | 33.57% | 5.50% | 20.87% | 1.32% |
| EBIT | 47.96% | 38.82% | 11.03% | 26.19% | -1.87% |
| EBITDA | 49.28% | 39.09% | 10.14% | 26.50% | -2.12% |
| EPS Basic | 42.97% | 36.74% | 9.87% | 24.36% | 5.33% |
| Normalized Basic EPS | 43.49% | 36.84% | 10.00% | 25.46% | 4.91% |
| EPS Diluted | 42.97% | 36.74% | 9.87% | 24.36% | 5.33% |
| Normalized Diluted EPS | 43.49% | 36.84% | 10.00% | 25.46% | 4.91% |
| Average Basic Shares Outstanding | 5.47% | 5.04% | 4.86% | 4.60% | 4.23% |
| Average Diluted Shares Outstanding | 5.47% | 5.04% | 4.86% | 4.60% | 4.23% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |